Regulators in the European Union (EU) have granted conditional approval to Rezdiffra (resmetirom) for some people with metabolic dysfunction-associated steatohepatitis…
Articles by Lila Levinson, PhD
Chemomab Therapeutics has aligned with U.S. regulators on several aspects of the late-stage development of nebokitug, its candidate therapy…
High maternal levels of liver damage markers in the blood can predict poor fetal outcomes in twin pregnancies affected by…
People with Alagille syndrome display different disease characteristics depending on whether the disease-causing mutation is located in the JAG1…
An unreported mutation in the JAG1 gene was identified as the likely cause of Alagille syndrome in a 28-year-old…
Hoth Therapeutics will support a U.S. Department of Veterans Affairs (VA) study testing treatment with glial cell-derived neurotrophic factor…
Combined treatment with phenobarbital and ursodeoxycholic acid (UDCA) is superior to phenobarbital alone at treating cholestasis symptoms, and does…
The European Medicines Agency (EMA) will review an application for linerixibat, an experimental oral therapy for intense itching associated with…
Note: This story was updated Aug. 8, 2025, to correct that infectious mononucleosis was linked to a 4.6 times higher…
A combination of two mutations in the MYO5B gene, including one that has not been previously reported, was the likely…